The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Docetaxel Winthrop

80/4 milligram(s)/millilitre Concentrate for solution for infusion

Zentiva k.s.EU/1/07/384/004

Main Information

Trade NameDocetaxel Winthrop
Active SubstancesDocetaxel trihydrate
Strength80/4 milligram(s)/millilitre
Dosage FormConcentrate for solution for infusion
Licence HolderZentiva k.s.
Licence NumberEU/1/07/384/004

Group Information

ATC CodeL01CD Taxanes
L01CD02 docetaxel


Licence Issued30/11/2009
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).
Marketing Status


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back